Literature DB >> 12452848

Abnormal expression of intracellular cytokines and chemokine receptors in peripheral blood T lymphocytes from patients with systemic sclerosis.

H Fujii1, M Hasegawa, K Takehara, N Mukaida, S Sato.   

Abstract

In patients with systemic sclerosis (SSc), there are conflicting findings regarding which is predominant between type 1 and type 2 immune responses. To determine the balance between type 1 and type 2 T lymphocytes in peripheral blood from SSc patients, we investigated the expression of intracellular cytokines, such as interferon-gamma (IFN-gamma), interleukin-2 (IL-2), IL-4, and IL-13, and chemokine receptors such as CXCR3 and CCR4 by flow cytometry. The frequency of IFN-gamma-producing cells among CD8+ cells was significantly increased in patients with diffuse cutaneous SSc (n = 11, P < 0.0001) and limited cutaneous SSc (lSSc; n= 16, P < 0.0001) compared with normal controls (n = 17) while there was no significant difference in the frequency of IL-4- or IL-13-producing cells. In contrast, the frequency of IFN-gamma- or IL-4-producing cells among CD4+ cells was similar between the three groups. Similar results were obtained when absolute numbers were assessed. The frequency of IFN-gamma-producing cells among CD8+ cells inversely correlated with percentage DLco in SSc patients (r = - 0.650, P < 0.005). CXCR3+ CD8+ cells selectively produced IFN-gamma, and the frequency of CXCR3+ CD45RO+ cells among CD8+ cells was higher in lSSc patients (n = 14, P < 0.01) than in normal controls (n = 22). In contrast, there was no significant difference in the frequencies of CXCR3- or CCR4-expressing CD45RO+ cells among CD4+ cells. These results demonstrate the predominance of type 1 cytokine-producing cells (Tc1 cells) in peripheral blood CD8+ T cells from SSc patients, but no definite Th1/Th2 imbalance in CD4+ T cells. Tc1 cells may be associated with pulmonary vascular damage in SSc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12452848      PMCID: PMC1906557          DOI: 10.1046/j.1365-2249.2002.02017.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  42 in total

1.  CCR4 memory CD4+ T lymphocytes are increased in peripheral blood and lesional skin from patients with atopic dermatitis.

Authors:  T Nakatani; Y Kaburagi; Y Shimada; M Inaoki; K Takehara; N Mukaida; S Sato
Journal:  J Allergy Clin Immunol       Date:  2001-02       Impact factor: 10.793

Review 2.  T-cell subsets (Th1 versus Th2).

Authors:  S Romagnani
Journal:  Ann Allergy Asthma Immunol       Date:  2000-07       Impact factor: 6.347

3.  Circulating gamma/delta T lymphocytes from systemic sclerosis (SSc) patients display a T helper (Th) 1 polarization.

Authors:  R Giacomelli; P Cipriani; A Fulminis; G Barattelli; M Matucci-Cerinic; S D'Alò; G Cifone; G Tonietti
Journal:  Clin Exp Immunol       Date:  2001-08       Impact factor: 4.330

4.  Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.

Authors:  E C LeRoy; C Black; R Fleischmajer; S Jablonska; T Krieg; T A Medsger; N Rowell; F Wollheim
Journal:  J Rheumatol       Date:  1988-02       Impact factor: 4.666

5.  Simultaneous production of IL-2, IL-4, and IFN-gamma by activated human CD4+ and CD8+ T cell clones.

Authors:  X Paliard; R de Waal Malefijt; H Yssel; D Blanchard; I Chrétien; J Abrams; J de Vries; H Spits
Journal:  J Immunol       Date:  1988-08-01       Impact factor: 5.422

6.  Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis.

Authors:  V D Steen; D L Powell; T A Medsger
Journal:  Arthritis Rheum       Date:  1988-02

7.  Rules of chemokine receptor association with T cell polarization in vivo.

Authors:  C H Kim; L Rott; E J Kunkel; M C Genovese; D P Andrew; L Wu; E C Butcher
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

8.  CRTH2 is the most reliable marker for the detection of circulating human type 2 Th and type 2 T cytotoxic cells in health and disease.

Authors:  L Cosmi; F Annunziato; K Nagata; S Romagnani
Journal:  Eur J Immunol       Date:  2000-10       Impact factor: 5.532

9.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05

10.  Lung inflammation in scleroderma: clinical, radiographic, physiologic and cytopathological features.

Authors:  J D Edelson; R H Hyland; M Ramsden; D W Chamberlain; P Kortan; H O Meindok; M H Klein; A C Braude; P Lee; A S Rebuck
Journal:  J Rheumatol       Date:  1985-10       Impact factor: 4.666

View more
  18 in total

1.  Mapping of the immunodominant T cell epitopes of the protein topoisomerase I.

Authors:  S Veeraraghavan; E A Renzoni; H Jeal; M Jones; J Hammer; A U Wells; C M Black; K I Welsh; R M du Bois
Journal:  Ann Rheum Dis       Date:  2004-08       Impact factor: 19.103

2.  Higher levels of serum interleukin-35 are associated with the severity of pulmonary fibrosis and Th2 responses in patients with systemic sclerosis.

Authors:  Jie Tang; Ling Lei; Jie Pan; Cheng Zhao; Jing Wen
Journal:  Rheumatol Int       Date:  2018-05-30       Impact factor: 2.631

3.  CD8+ T cells in systemic sclerosis.

Authors:  Patrizia Fuschiotti
Journal:  Immunol Res       Date:  2011-08       Impact factor: 2.829

4.  Alterations of mononuclear inflammatory cells, CD4/CD8+ T cells, interleukin 1beta, and tumour necrosis factor alpha in the bronchoalveolar lavage fluid, peripheral blood, and skin of patients with systemic sclerosis.

Authors:  M R Hussein; H I Hassan; E R M Hofny; M Elkholy; N A Fatehy; A E A Abd Elmoniem; A M Ezz El-Din; O A Afifi; H G Rashed
Journal:  J Clin Pathol       Date:  2005-02       Impact factor: 3.411

5.  Is spleen circulation impaired in systemic sclerosis and what is the role of liver fibrosis?

Authors:  Giovanni Tarantino; Angelo Spanò; Gabriella Loi; Anna Parisi; Marianna Tarantino; Giuseppina Brancaccio; Giovanni Battista Gaeta; Antonio Riccio
Journal:  World J Gastroenterol       Date:  2011-03-28       Impact factor: 5.742

6.  T cell polarization identifies distinct clinical phenotypes in scleroderma lung disease.

Authors:  Francesco Boin; Umberto De Fanis; Susan J Bartlett; Fredrick M Wigley; Antony Rosen; Vincenzo Casolaro
Journal:  Arthritis Rheum       Date:  2008-04

7.  X chromosome gene methylation in peripheral lymphocytes from monozygotic twins discordant for scleroderma.

Authors:  C Selmi; C A Feghali-Bostwick; A Lleo; S A Lombardi; M De Santis; F Cavaciocchi; L Zammataro; M M Mitchell; J M Lasalle; T Medsger; M E Gershwin
Journal:  Clin Exp Immunol       Date:  2012-09       Impact factor: 4.330

Review 8.  Current perspectives on the role of CD8+ T cells in systemic sclerosis.

Authors:  Patrizia Fuschiotti
Journal:  Immunol Lett       Date:  2017-10-05       Impact factor: 3.685

9.  Cytokine and chemokine levels in systemic sclerosis: relationship with cutaneous and internal organ involvement.

Authors:  E Scala; S Pallotta; A Frezzolini; D Abeni; C Barbieri; F Sampogna; O De Pità; P Puddu; R Paganelli; G Russo
Journal:  Clin Exp Immunol       Date:  2004-12       Impact factor: 4.330

10.  Iloprost modulates the immune response in systemic sclerosis.

Authors:  Patrizia D'Amelio; Maria A Cristofaro; Lucia D'Amico; Luciana Veneziano; Ilaria Roato; Francesca Sassi; Giuseppina Bisignano; Marta Saracco; Raffaele Pellerito; Salvatore Patanè; Riccardo Ferracini; Gian P Pescarmona; Giovanni C Isaia
Journal:  BMC Immunol       Date:  2010-12-15       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.